scholarly journals Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers

2020 ◽  
Author(s):  
Saskia Lisa Verhaart ◽  
Yasmin Abu-Ghanem ◽  
Sasja F. Mulder ◽  
Sjoukje Oosting ◽  
Astrid Van Der Veldt ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
The Netherlands ◽  
Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Predictive Markers ◽  
Advanced Renal Cell Carcinoma ◽  
Real World Data ◽  
World Data

REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis

2015 ◽  
Vol 11 (21) ◽  
pp. 2893-2903 ◽  
Author(s):  
Sergio Bracarda ◽  
Sylvie Rottey ◽  
Amit Bahl ◽  
Christian Eichelberg ◽  
Begoña Mellado ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Real World Data ◽  
World Data ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

scholarly journals Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment

2022 ◽  
Vol 35 ◽  
pp. 54-58
Author(s):  
Aafke Meerveld-Eggink ◽  
Niels Graafland ◽  
Sofie Wilgenhof ◽  
Johannes V. Van Thienen ◽  
Ferry Lalezari ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Tumour Response ◽  
Renal Tumour ◽  
Real World Data ◽  
World Data ◽  
Data Assessment
Sign in / Sign up

Export Citation Format

Share Document